— der for lægemidlet X er opnået en markedsføringstilladelse i medlemsstat A, og lægemidlet var omfattet af en markedsføringstilladelse, som ikke længere var gyldig i medlemsstat Β
— medicinal product X is the subject of a marketing authorisation granted in Member State A and was the subject of a marketing authorisation which has ceased to have effect in Member State B;